Trials / Completed
CompletedNCT01372956
Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea
Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea (CRESCENDO)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,950 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-centre, cross-sectional, chart review study to investigate cholesterol goal attainment rates defined by modified NCEP-ATP III guidelines and define its possible determinants among Korean dyslipidemic patients
Detailed description
MC MD
Conditions
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2011-06-14
- Last updated
- 2011-12-22
Locations
20 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01372956. Inclusion in this directory is not an endorsement.